Join series hosts Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer at Healing Our Village, in Atlanta, GA; Dr. Aaron King, Family Medicine Physician with Baptist Health System Physicians, in San Antonio, TX; Dr. Jennifer Goldman, Professor of Pharmacy at Massachusetts College of Pharmacy, in Boston, MA, and Clinical Pharmacist at Well Life Medical, in Peabody, MA, and other fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include the disease state of T2D, clinical inertia, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as the mechanism of action, dosing and administration, efficacy and safety profiles, handling and storage, education of patients and pharmacists, and frequently asked questions regarding a once daily GLP-1 RA for adults with T2D.

This podcast series is sponsored by Novo Nordisk and is intended for clinicians.